Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Removed Melanoma and related topics such as MedlinePlus Genetics from the Study Details page.
    Difference
    0.2%
    Check dated 2026-02-25T07:48:52.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Small editorial updates were made, including adding Melanoma and related topics (MedlinePlus Genetics) and a new revision tag (v3.4.2), while the funding notice and the previous revision tag (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T01:45:48.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A general site-wide notice about government funding and NIH status was added, along with a revision tag (Rev. 3.4.1); Melanoma-related topics and MedlinePlus Genetics were removed from related topics.
    Difference
    0.6%
    Check dated 2026-02-03T22:44:05.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Includes a glossary and related topic links (Melanoma, MedlinePlus Genetics) to improve understanding and navigation of the study details. Adds minor metadata updates, including capitalization normalization of QC criteria text and a revision/version change.
    Difference
    0.4%
    Check dated 2026-01-27T20:42:58.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added and v3.3.3 removed.
    Difference
    0.1%
    Check dated 2026-01-20T14:37:51.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added Melanoma and related-topic references (MedlinePlus Genetics), a Locations section including Virginia, and a footer revision to v3.3.3, while removing HHS Vulnerability Disclosure and Virginia Locations with an update to v3.3.2.
    Difference
    0.4%
    Check dated 2025-12-22T22:45:08.000Z thumbnail image

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.